Memo
The conference will be of special interest to researchers and clinician-scientists in academia, as well as colleagues from biotechnology and pharmaceutical industries, working in the areas of cardiovascular medicine and biology, immunology, metabolic diseases, immuno-metabolism, molecular and cellular biology, and epigenetics.